These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 25929316)
1. On the Analytical Superiority of 1D NMR for Fingerprinting the Higher Order Structure of Protein Therapeutics Compared to Multidimensional NMR Methods. Poppe L; Jordan JB; Rogers G; Schnier PD Anal Chem; 2015 Jun; 87(11):5539-45. PubMed ID: 25929316 [TBL] [Abstract][Full Text] [Related]
2. Application of Natural Isotopic Abundance ¹H-¹³C- and ¹H-¹⁵N-Correlated Two-Dimensional NMR for Evaluation of the Structure of Protein Therapeutics. Arbogast LW; Brinson RG; Marino JP Methods Enzymol; 2016; 566():3-34. PubMed ID: 26791974 [TBL] [Abstract][Full Text] [Related]
3. Principal Component Analysis of 1D 1H Diffusion Edited NMR Spectra of Protein Therapeutics. Elliott KW; Delaglio F; Wikström M; Marino JP; Arbogast LW J Pharm Sci; 2021 Oct; 110(10):3385-3394. PubMed ID: 34166704 [TBL] [Abstract][Full Text] [Related]
4. NMR spectroscopy as a characterization tool enabling biologics formulation development. Ma J; Pathirana C; Liu DQ; Miller SA J Pharm Biomed Anal; 2023 Jan; 223():115110. PubMed ID: 36308923 [TBL] [Abstract][Full Text] [Related]
12. Simple NMR methods for evaluating higher order structures of monoclonal antibody therapeutics with quinary structure. Chen K; Long DS; Lute SC; Levy MJ; Brorson KA; Keire DA J Pharm Biomed Anal; 2016 Sep; 128():398-407. PubMed ID: 27344629 [TBL] [Abstract][Full Text] [Related]
13. Correction to On the Analytical Superiority of 1D NMR for Fingerprinting the Higher Order Structure of Protein Therapeutics Compared to Multidimensional NMR Methods. Poppe L; Jordan JB; Rogers G; Schnier PD Anal Chem; 2015 Jul; 87(14):7493. PubMed ID: 26125133 [No Abstract] [Full Text] [Related]
14. NMR Spectroscopy for Protein Higher Order Structure Similarity Assessment in Formulated Drug Products. Wang D; Zhuo Y; Karfunkle M; Patil SM; Smith CJ; Keire DA; Chen K Molecules; 2021 Jul; 26(14):. PubMed ID: 34299526 [TBL] [Abstract][Full Text] [Related]
15. Use of the 2D Hwang TL; Batabyal D; Knutson N; Wikström M Molecules; 2021 May; 26(9):. PubMed ID: 34063095 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive characterization of higher order structure changes in methionine oxidized monoclonal antibodies via NMR chemometric analysis and biophysical approaches. Li M; Beaumont VA; Akbar S; Duncan H; Creasy A; Wang W; Sackett K; Marzilli L; Rouse JC; Kim HY MAbs; 2024; 16(1):2292688. PubMed ID: 38117548 [TBL] [Abstract][Full Text] [Related]
17. Application of NMR and Chemometric Analyses to Better Understand the Quality Attributes in pH and Thermally Degraded Monoclonal Antibodies. Beaumont VA; Liu L; Shi H; Rouse JC; Kim HY Pharm Res; 2023 Oct; 40(10):2457-2467. PubMed ID: 37798537 [TBL] [Abstract][Full Text] [Related]
18. Solid-State NMR Characterization of Lyophilized Formulations of Monoclonal Antibody Therapeutics. Perodeau J; Arbogast LW; Nieuwkoop AJ Mol Pharm; 2023 Mar; 20(3):1480-1489. PubMed ID: 36702622 [TBL] [Abstract][Full Text] [Related]